Product Information
QNASL CHILDREN'S 40 MCG SPRAY is a brand product labeled by Teva Respiratory, LLC, priced at $47.0275 per GM under NDC 59310040606. Its NADAC has been published 371 times since May 22, 2019.
Strength
40 ug/1
Manufacturer
Teva Respiratory, LLCNDC
59310040606
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
NASAL
Last Updated
6/17/2026
Active Ingredients
BECLOMETHASONE DIPROPIONATEApproval Type
New Drug (NDA)
FDA Application
NDA202813On Market Since
1/2/2019
Pharmacological Classes
Price Statistics
The NADAC for QNASL CHILDREN'S 40 MCG SPRAY has been published 371 times since May 22, 2019, and over the history we have for it it has risen 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $47.0275 per GM |
|---|---|
| All-time high | $47.3017 (May 13, 2026) |
| All-time low | $32.3129 (May 22, 2019) |
| 52-week high | $47.3017 |
| 52-week low | $44.9577 |
| Median price | $39.8706 |
| Average price | $39.8252 |
| Largest weekly change | +9.4% (Jan 12, 2022) |
| Weeks tracked | 371 |
| Tracking since | May 22, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Beclomethasone Dipropionate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QNASL CHILDREN'S 40 MCG SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for QNASL CHILDREN'S 40 MCG SPRAY, manufactured by Teva Respiratory, LLC, is $47.0275 per GM (NDC 59310040606), effective Jun 24, 2026.
How has the price of QNASL CHILDREN'S 40 MCG SPRAY changed over time?
Over the history we have for it, the NADAC for QNASL CHILDREN'S 40 MCG SPRAY has risen 45.5%. It has been tracked across 371 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for QNASL CHILDREN'S 40 MCG SPRAY?
Since May 22, 2019, the NADAC for QNASL CHILDREN'S 40 MCG SPRAY has ranged from a low of $32.3129 (May 22, 2019) to a high of $47.3017 (May 13, 2026), with a median of $39.8706 per GM.
Are there cheaper alternatives to QNASL CHILDREN'S 40 MCG SPRAY?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QNASL CHILDREN'S 40 MCG SPRAY, so no direct lower-cost alternative is listed.
Who manufactures QNASL CHILDREN'S 40 MCG SPRAY?
QNASL CHILDREN'S 40 MCG SPRAY (NDC 59310040606) is labeled by Teva Respiratory, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification